Literature DB >> 2044584

Diagnosis of chronic granulomatous disease and of its mode of inheritance by dihydrorhodamine 123 and flow microcytofluorometry.

J Roesler1, M Hecht, J Freihorst, M L Lohmann-Matthes, A Emmendörffer.   

Abstract

Dihydrorhodamine 123 (DHR) attached to membranes of granulocytes (PMN) and monocytes is caused to fluoresce by reactive oxygen intermediates (ROI) indicating the ability of phagocytes to produce these microbicide metabolites in a flow microcytofluorimeter. Whole blood samples from five boys with known chronic granulomatous disease (CGD) and from their mothers (and from one father and one grandmother), were examined following erythrocyte lysis in order to test this new method. An incubation period of 10 min with phorbol-myristate-acetate, followed by another 15 min incubation period with DHR before flow microcytofluorimetric analysis of 5 or 10 x 10(3) phagocytes, was sufficient to obtain the following results. PMN and monocytes from four patients with CGD could clearly not produce any ROI whereas cells from one patient displayed decreased activity in ROI production as compared to cells from a healthy donor. The X-linked mode of inheritance was detected in six carriers by the presence of two different cell populations (one normal ROI-producing and one negative or less active population). All the phagocytes from one mother produced ROI in normal amounts suggesting an autosomal mode of inheritance. All in all, the method presented provides a fast and most simple tool to diagnose CGD, to determine a decrease or total lack of ROI production and to establish the mode of inheritance of the disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2044584     DOI: 10.1007/bf01963557

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  7 in total

1.  Dihydrorhodamine 123: a new flow cytometric indicator for respiratory burst activity in neutrophil granulocytes.

Authors:  G Rothe; A Oser; G Valet
Journal:  Naturwissenschaften       Date:  1988-07

2.  The NBT slide test: a simple screening method for detecting chronic granulomatous disease and female carriers.

Authors:  H D Ochs; R P Igo
Journal:  J Pediatr       Date:  1973-07       Impact factor: 4.406

3.  Monoclonal antibody 7D5 raised to cytochrome b558 of human neutrophils: immunocytochemical detection of the antigen in peripheral phagocytes of normal subjects, patients with chronic granulomatous disease, and their carrier mothers.

Authors:  M Nakamura; M Murakami; T Koga; Y Tanaka; S Minakami
Journal:  Blood       Date:  1987-05       Impact factor: 22.113

4.  Phorbol myristate acetate induced oxidation of 2',7'-dichlorofluorescin by neutrophils from patients with chronic granulomatous disease.

Authors:  N F Hassan; D E Campbell; S D Douglas
Journal:  J Leukoc Biol       Date:  1988-04       Impact factor: 4.962

5.  Absence of cytochrome b-245 in chronic granulomatous disease. A multicenter European evaluation of its incidence and relevance.

Authors:  A W Segal; A R Cross; R C Garcia; N Borregaard; N H Valerius; J F Soothill; O T Jones
Journal:  N Engl J Med       Date:  1983-02-03       Impact factor: 91.245

6.  Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation.

Authors:  D A Bass; J W Parce; L R Dechatelet; P Szejda; M C Seeds; M Thomas
Journal:  J Immunol       Date:  1983-04       Impact factor: 5.422

7.  Flow cytometric quantitation of oxidative product formation by polymorphonuclear leukocytes during phagocytosis.

Authors:  P Szejda; J W Parce; M S Seeds; D A Bass
Journal:  J Immunol       Date:  1984-12       Impact factor: 5.422

  7 in total
  16 in total

Review 1.  Neutrophil disorders and their management.

Authors:  R Lakshman; A Finn
Journal:  J Clin Pathol       Date:  2001-01       Impact factor: 3.411

2.  Are soluble factors relevant for polymorphonuclear leukocyte dysregulation in septicemia?

Authors:  C Wenisch; W Graninger
Journal:  Clin Diagn Lab Immunol       Date:  1995-03

3.  Effect of single oral dose of azithromycin, clarithromycin, and roxithromycin on polymorphonuclear leukocyte function assessed ex vivo by flow cytometry.

Authors:  C Wenisch; B Parschalk; K Zedtwitz-Liebenstein; A Weihs; I el Menyawi; W Graninger
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

4.  Effect of ciprofloxacin and other quinolones on granulocyte function assessed by flow cytometry.

Authors:  C Wenisch; P Parschalk; W Graninger
Journal:  Drugs       Date:  1995       Impact factor: 9.546

5.  Rapid whole-blood flow cytometry assay for diagnosis of chronic granulomatous disease.

Authors:  M R O'Gorman; V Corrochano
Journal:  Clin Diagn Lab Immunol       Date:  1995-03

Review 6.  The molecular basis of chronic granulomatous disease.

Authors:  C Meischl; D Roos
Journal:  Springer Semin Immunopathol       Date:  1998

7.  Simian immunodeficiency virus lentivector corrects human X-linked chronic granulomatous disease in the NOD/SCID mouse xenograft.

Authors:  N Naumann; S S De Ravin; U Choi; M Moayeri; N Whiting-Theobald; G F Linton; Y Ikeda; H L Malech
Journal:  Gene Ther       Date:  2007-08-30       Impact factor: 5.250

8.  X-linked chronic granulomatous disease secondary to skewed X chromosome inactivation in a female with a novel CYBB mutation and late presentation.

Authors:  Eric M Lewis; Manav Singla; Susan Sergeant; Patrick P Koty; Linda C McPhail
Journal:  Clin Immunol       Date:  2008-09-06       Impact factor: 3.969

Review 9.  Chronic granulomatous disease: a 25-year patient registry based on a multistep diagnostic procedure, from the referral center for primary immunodeficiencies in Greece.

Authors:  Maria Raptaki; Ioanna Varela; Kleopatra Spanou; Marianna Tzanoudaki; Sofia Tantou; Manolis Liatsis; Nikki Constantinidou; Chryssa Bakoula; Dirk Roos; Maria Kanariou
Journal:  J Clin Immunol       Date:  2013-10-01       Impact factor: 8.317

10.  Effect of cefodizime and ceftriaxone on phagocytic function in patients with severe infections.

Authors:  C Wenisch; B Parschalk; M Hasenhündl; E Wiesinger; W Graninger
Journal:  Antimicrob Agents Chemother       Date:  1995-03       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.